Sendai Medical Center
Sendai, Miyagi, Japan
General hospital in Sendai
1 Chome-1-1 Asutonagamachi, Taihaku Ward, Sendai, Miyagi 982-8502
About Sendai Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Arena Pharmaceuticals
2
Merck Sharp & Dohme LLC
2
AstraZeneca
1
Japan Clinical Cancer Research Organization
1
Pfizer
1
Sumitomo Pharma Co., Ltd.
1
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
1
Clinical Trials at Sendai Medical Center
During the past decade, Sendai Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
2008-03-01
2011-06-01
Completed
300
Study of DSP-7888 in Patients With Myelodysplastic Syndrome
2015-05-01
2020-03-01
Completed
48
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
2015-12-18
2016-06-01
Completed
1,232
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
2019-09-05
2027-01-31
Recruiting
900
Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
2019-06-28
2024-12-30
Active, not recruiting
1,005
A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)
2019-06-28
2024-12-30
Active, not recruiting
857
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
2020-09-15
2021-12-07
Completed
354
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sendai Medical Center" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials
sponsored, "AstraZeneca" with 1 trials sponsored, "Japan Clinical Cancer Research Organization" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sendai Medical Center"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Sendai Medical Center
According to Clinical.Site data, the most researched conditions in "Sendai Medical Center" are
"Ulcerative Colitis" (3 trials), "Asthma" (1 trials), "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials), "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Sendai Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Sendai Medical Center
Most popular intervention types in "Sendai Medical Center" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Etrasimod" (3 trials), "Placebo" (3 trials), "Carboplatin" (2 trials), "Olaparib" (2 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Sendai Medical Center
The vast majority of trials in "Sendai Medical Center" are
9 trials for "All" genders.
Clinical Trials Status at Sendai Medical Center
Currently, there are NaN active trials in "Sendai Medical Center".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Sendai Medical Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sendai Medical Center, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".